Stem Cell Banking Market Analysis, Share and Future Scope

by Vijay K. Web Marketing
Stem cells are the cells that have the potential to differentiate into various types of cells in the body. Embryonic stem cells and adult stem cells are the two main types of stem cells. Stem cells could possibly be used to generate cells and tissues for therapy of a variety of diseases including Alzheimer's disease, Parkinson's disease, heart disease, spinal cord injury, diabetes, and arthritis. The global stem cell banking market is expected to grow due to the increasing prevalence of such diseases and increasing awareness among people about the need to preserve stem cells. The umbilical cord blood of the newborn is an abundant source of stem cells. However, some tissues and organs within body, skin, blood, and the lining of intestine are also key source of tissue-specific stem cells. The stem cells are separated from the blood or tissue, processed, tested and preserved in a stem cell bank.

These stored stem cells have application in treating various types of blood disease as well as genetic disorders such as sickle cell anemia, thalassemia, leukemia, and immune disorders. According to the National Cancer Institute, the incidence of leukemia was 13.7 per 100,000 men and women per year between 2010 to 2014 in the U.S. Therefore, the overall demand for stem cell based therapies and stem cell banking is increasing, which is expected to drive the growth of the global stem cell banking market. National Cancer Institute a part of the National Institutes of Health (NIH), is the principal agency for cancer training and research of the U.S. Federal Government.

The stem cell market is expected to grow during the forecast period mainly due to the easy extraction methods used and increasing awareness about stem cell therapeutics and their potential in treating various diseases. According to World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases in 2012 and the number of new cases are expected to rise by about 70% over the next two decades. With promising results with stem cell therapies in treating such disorders, the increased incidence of these disease is expected to act as a driving factor for the growth of the global stem cell banking market.

The rising awareness about potential use of cord tissue, collaborations of cord blood banks to gain a larger market share and the with the introduction of various automated procedures being developed in the field of science are expected to provide abundant opportunities to the manufacturers in the global stem cell banking market. In June 2017, Americord started a social media campaign for National Cord Blood Awareness Month to create awareness about various diseases currently being treated with cord blood stem cells.

Many players in the global stem cell banking market are collaborating to expand their presence in new geographies and also to get access to the proprietary technologies of other companies.

In June 2017, LifeCodexx AG, a provider of non-invasive prenatal DNA testing in the Europe, announced its partnership with LifeCell International Pvt. Ltd., an Indian mother & baby preventive health care provider, to bring PrenaTesT, qNIPT testing for the first time to India. The qNIPT technology that detects the presence of foetal trisomy 21 (Down Syndrome) from maternal blood, received CE marking (European Conformity) in December 2016.

Some of the major players operating in the stem cell banking market include Cordlife Group Ltd, Cryocell International, Inc., Lifecell International Pvt. Ltd., PerkinElmer, Inc. (Viacord), StemCyte Inc., CryoSave AG, China Cord Blood Corporation, Cord Blood America, Inc., Caladrius Biosciences Inc., CBR Systems, Inc., Cordvida, Cordviva India.

About Vijay K. Advanced   Web Marketing

106 connections, 2 recommendations, 296 honor points.
Joined APSense since, May 17th, 2016, From New York, United States.

Created on Dec 11th 2018 05:44. Viewed 77 times.


No comment, be the first to comment.
Please sign in before you comment.